"Clinical use of drotrecogin alfa (activated): Patients treated in mercury differ from those in PROWESS." by Jay Steingrub, MD

Selected Works of Jay Steingrub MD

Follow Contact

Article

Clinical use of drotrecogin alfa (activated): Patients treated in mercury differ from those in PROWESS.

All Scholarly Works

Jay Steingrub, MD, Baystate Health

Document Type

Presentations, Research

Publication Date

12-1-2003

Citation Information

Schmidt G, Bates B, Shwed McCollam J, Steingrub JS. Clinical use of drotrecogin alfa (activated): Patients treated in mercury differ from those in PROWESS. Society of Critical Care Medicine 34th Critical Care Congress. San Antonio, TX. Jan 28-Feb 2, 2003.